FDAnews Drug Daily Bulletin

Teva to Acquire Ratiopharm in Deal Valued Near $5 Billion

March 19, 2010
A A
Teva Pharmaceutical Industries Ltd. won the bidding for generic-drug manufacturer Ratiopharm, agreeing to buy the German firm in a deal valued at 3.63 billion euros ($4.97 billion).
MarketWatch